Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Carcinoma Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04712903
What this trial is testing

Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 101
Large-scale testing (Phase 3)Study completedNCT01450761
What this trial is testing

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 1,351
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT05245994
What this trial is testing

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Who this might be right for
Lung CancerSmall Cell Lung CancerDurvalumab
Li Zhang, MD 60
Testing effectiveness (Phase 2)WithdrawnNCT00104754
What this trial is testing

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00240097
What this trial is testing

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

Who this might be right for
Non-Small Cell Lung Cancer
University of Alabama at Birmingham 30
Large-scale testing (Phase 3)Study completedNCT00045162
What this trial is testing

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 671
Testing effectiveness (Phase 2)Study completedNCT00003943
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Who this might be right for
Carcinoma of Unknown PrimaryLung Cancer
Fox Chase Cancer Center 3
Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Early research (Phase 1)Ended earlyNCT00807755
What this trial is testing

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 5
Testing effectiveness (Phase 2)Study completedNCT02580994
What this trial is testing

Pembrolizumab in Untreated Extensive SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
European Organisation for Research and Treatment of Cancer - EORTC 125
Testing effectiveness (Phase 2)Study completedNCT00006082
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 38
Testing effectiveness (Phase 2)UnknownNCT01977235
What this trial is testing

Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Third Military Medical University 110
Testing effectiveness (Phase 2)Study completedNCT00613626
What this trial is testing

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hoosier Cancer Research Network 74
Early research (Phase 1)Study completedNCT00884598
What this trial is testing

Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer

Who this might be right for
Brain and Central Nervous System TumorsLung Cancer
Universitätsmedizin Mannheim 19
Testing effectiveness (Phase 2)Study completedNCT00049218
What this trial is testing

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07547332
What this trial is testing

Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC

Who this might be right for
Small Cell Lung CancerExtensive Stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Pulmonary Hospital, Shanghai, China 84
Testing effectiveness (Phase 2)UnknownNCT05901584
What this trial is testing

Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Who this might be right for
ImmunotherapySecond-line Treatment
Second Affiliated Hospital of Zunyi Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07803848
What this trial is testing

Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status

Who this might be right for
Small-cell Lung Cancer
AIO-Studien-gGmbH 57
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Next Page